COMMUNIQUÉS West-GlobeNewswire

-
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
10/12/2024 -
COVID Non-pharmaceutical Interventions Were Harmful Authoritarian Overreach, according to Journal of American Physicians and Surgeons
10/12/2024 -
Thought Leadership & Innovation Foundation Celebrates the Launch of Autism Knowledge Gateway
10/12/2024 -
Neuronetics and Greenbrook TMS Announce Closing of Transaction
10/12/2024 -
Soda Health Adds Walgreens to Network of Integrated Retailers, Serving More than 100 Million Medicare Advantage and Medicaid Members
10/12/2024 -
Brain Cancer Canada Awards a $50,000 Grant to Discover How to Use the Body’s Own Immune Cells to Attack Pediatric Brain Cancers
10/12/2024 -
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
10/12/2024 -
Immix Biopharma Announces 75% Complete Response Rate (n=16); 31.5 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2024
10/12/2024 -
India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way
10/12/2024 -
HWH International Inc. and Guangzhou Inbot Technology Ltd Announce Strategic Partnership to Drive Global Robotics Expansion
10/12/2024 -
BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health
10/12/2024 -
UPDATE – Health-ISAC Bestows Newly Renamed Steve Katz Hero Award
10/12/2024 -
WeightWatchers Unveils Next-Gen Program With AI-Powered App Features
10/12/2024 -
Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium
10/12/2024 -
Visory Health Joins Fast Company's Esteemed 2024 Brands That Matter List
10/12/2024 -
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
10/12/2024 -
Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer
10/12/2024 -
H1 Partners with CTI to Streamline Clinical Trial PI and Site Selection for More Inclusive and Efficient Trials
10/12/2024 -
ACC Medlink Highlights Commitment to Excellence in Patient Care at ACMA Case Management Conference
10/12/2024
Pages